Where does Oasis Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Oasis Medical, Inc. ranks #18,967 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Oasis Medical, Inc. hold?

Oasis Medical, Inc. holds 15 US utility patents granted between 2015 and 2025, spanning 4 technology areas.

What is Oasis Medical, Inc.'s Innovation Score?

Oasis Medical, Inc. has an Innovation Score of 38.2 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Oasis Medical, Inc. focus on?

Oasis Medical, Inc.'s top technology area is H04L (Transmission OF Digital Information, e.g. Telegraphic Communication) with 7 patents, ranking #3,127 of 8,956 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Oasis Medical, Inc.'s patent grant rate increasing or decreasing?

Oasis Medical, Inc.'s recent grant velocity is +500% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Oasis Medical, Inc.'s patents?

Oasis Medical, Inc.'s patents average 13.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Oasis Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Oasis Medical, Inc.

USPTO PatentsView assignee record - 15 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04L (Transmission OF Digital Information, e.g. Telegraphic Communication).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Oasis ranks #18,967 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 4 technology areas.

#18,967
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.2/100): 13.7
avg claims per patent: +500%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18967 · US Corporation #18,967 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #18,967/49,997
PHOTO-FINISH Oasyschair
CPC-NARROW H04L · 4 areas
INNOV-THIN 38.2/100
CLAIMS-RICH 13.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +500% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Oasyschair Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Oasis’s 38.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (25%) Velocity 13.3 pts (35%) Breadth 7.1 pts (19%) Claim depth 8.2 pts (21%)

Qualcomm Incorporated · highest

85
Oasis Medical · this assignee

38
3D Lighting… · lowest

7

What this shows Oasis's Innovation Score is 38.2/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Oasis?

Each dot is one of Oasis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Oasis’s own 13.7 claims/patent is at or below the 16.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Oasis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Oasis's grants concentrate

Oasis Medical, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 46.7% of grants classified under H04L (Transmission OF Digital Information, e.g. Telegraphic Communication). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2021. By volume, Oasis sits between OTICO and OliX Pharmaceuticals. Inc..

Oasis's three-year grant acceleration

Oasis Medical, Inc. shows 8 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Otico

15
Otsuka America Ph…

15
Oxis Energy

15
Oxitec

15
Oasyschair

15
Obeebo Labs

15
Odfjell Well Serv…

15
Olix Pharmaceutic…

15
Oasis Medical ◀

15

What this shows Oasis holds 15 patents at rank #18,972, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Oasis

By rank, the assignees closest to #18,972 in granted patent volume.

Leaders in H04L (Transmission OF Digital Information)

Other assignees with the most granted patents in Oasis's primary technology class.

Oasis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Oasis Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	13.3%
2020	3	20.0%
2021	1	6.7%
2022	2	13.3%
2023	3	20.0%
2024	3	20.0%
2025partial year	1	6.7%

Which technologies does Oasis Medical, Inc. patent most?

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 7

G06F - Electric Digital Data Processing 3

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 3

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Oasis Medical, Inc.'s patent record in context - here's where to go next.

Oasis Medical, Inc.'s lead technology class is H04L (Transmission OF Digital Information, e.g. Telegraphic Communication), 46.7% of its portfolio - see every assignee active in that class. Explore H04L
Ranked #18,967 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Oasis Medical, Inc. against OTICO, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.